WASHINGTON (AP) - The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.
The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.
FDA says the approval was based on a company study of 137 advanced heart failure patients implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.
Medical device maker HeartWare International Inc. is based in Framingham, Mass.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Special Olympics New Mexico provides year-round sports training and athletic competition in a variety of olympic-type sports for children and adults with intellectual disabilities. Here to tell us more is Erin Gallegos, communication …
There is a cold front moving into the state this week and this is also the time that many families are making trips to visit families for the holidays. That makes it all the more important to remind you before you head out to keep an eye …
While pregnant, it's a good idea to stay healthy, exercise lightly and remain stress free. In your busy life this could be hard to do. Denise Gonzales, the manager from Blissful Spirits hot yoga studio, is here to show us some yoga moves …